Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.20%
1,108.23
-2.24
-0.20%
1,110.471,107.751,111.341,093.81
SIXC
Communications
SIXC
Communications
SIXC
+0.26%
605.63
+1.56
+0.26%
604.07604.07606.04600.91
SIXE
Energy
SIXE
Energy
SIXE
+0.70%
1,209.95
+8.46
+0.70%
1,201.491,205.921,215.311,201.02
SIXI
Industrials
SIXI
Industrials
SIXI
-0.40%
1,758.23
-7.07
-0.40%
1,765.301,764.031,764.031,736.40
SIXM
Financials
SIXM
Financials
SIXM
+0.72%
634.94
+4.52
+0.72%
630.42630.34636.69626.03
SIXR
Staples
SIXR
Staples
SIXR
+1.30%
852.37
+10.92
+1.30%
841.45843.60858.11840.11
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.01%
218.85
+0.020
+0.01%
218.83218.83219.32217.33
SIXT
Technology
SIXT
Technology
SIXT
-1.50%
3,528.49
-53.74
-1.50%
3,582.233,550.603,562.623,447.78
SIXU
Utilities
SIXU
Utilities
SIXU
+0.10%
914.82
+0.93
+0.10%
913.89912.75918.12906.67
SIXV
Health care
SIXV
Health care
SIXV
+1.93%
1,472.27
+27.94
+1.93%
1,444.331,446.871,480.741,446.30
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.93%
2,390.61
-22.35
-0.93%
2,412.962,403.992,411.412,373.90
2395:TYO
Shin Nippon Biomedical Laboratories Ltd
¥1,197.00
-2.21%
(-27.00) 1D
May 13, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 2395...
Open
¥1,221
High
¥1,224
Low
¥1,192
Mkt. cap
49.83B
Avg. vol.
254.46K
Volume
497.70K
Dividend
4.18%
Quarterly dividend
¥12
Ex dividend date
Sep 29, 2025
P/E ratio
10.91
52-wk high
¥2,005
52-wk low
¥1,192
EPS
¥110
Shares outstanding
41.63M
No. of employees
2K
News stories
From sources across the web
About Shin Nippon Biomedical Laboratories Ltd
CEO-
Employees1.53K
Founded1957
Headquarters-
SectorHealth care
Websitesnbl.co.jp
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
6.48B
8.29B
6.43B
11.33B
Cost of goods sold
3.41B
4.68B
2.20B
6.00B
Cost of revenue
3.41B
4.68B
2.20B
6.00B
Research and development expenses
-
-
-
2.40B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.41B
3.22B
3.25B
850.24M
Operating expense
3.41B
3.22B
3.25B
3.70B
Total operating expenses
6.82B
7.90B
5.45B
9.70B
Operating income
-340.94M
389.94M
978.59M
1.63B
Other non operating income
60.44M
54.56M
81.03M
105.77M
EBT including unusual items
333.50M
990.50M
1.43B
3.50B
EBT excluding unusual items
515.75M
1.11B
1.49B
2.71B
Income tax expense
77.00M
209.00M
229.77M
1.20B
Effective tax rate
23.09%
21.10%
16.11%
34.22%
Other operating expenses
-
-
-
-
Net income
260.42M
800.58M
1.21B
2.30B
Net profit margin
4.02%
9.66%
18.82%
20.26%
Earnings per share
-
-
-
-
Interest and investment income
7.68M
88.32M
14.12M
128.12M
Interest expense
-57.82M
-68.18M
-78.15M
-88.40M
Net interest expenses
-50.13M
20.13M
-64.03M
39.72M
Depreciation and amortization charges
-
-
-
411.00M
EBITDA
311.84M
1.17B
1.63B
2.28B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more